A Study of A166 in Patients With Advanced Solid Malignant Tumors
Clinical trial NCT05311397 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05311397
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-09
- Primary completion
- 2026-06-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.